Immatics
interim update phase phase cohort a key take limited number of confirmation of all objective | Immatics
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
7 of 25
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
October 2023
spy phase clinical trial design | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Day
October 2022
| Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
October 2023
spy phase clinical trial design | Aeglea BioTherapeutics
Anebulo Pharmaceuticals
Investor Day
September 2022
part cohorts and interim data conclusions | Anebulo Pharmaceuticals
Other recent decks by Immatics
See all presentations (2 decks)
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights